Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Caspase-1 helps hair stem cells move to heal wounded or inflamed skin.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Somatostatin helps hair follicles suppress immune responses, which might aid in treating certain hair loss conditions.

Scalp cooling reduces chemotherapy-induced hair loss without increasing risk of skin metastases.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

JAK inhibitors show promise in treating difficult skin diseases.

Cells from concentrated growth factor can become different cell types.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

A patient with complete hair loss regrew all her hair using tofacitinib.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Proinflammatory fibroblasts and vascular endothelial cells are key in keloid development.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Certain topical drugs can regrow hair in mice.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Targeting specific cell interactions may help treat skin fibrosis.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

WIF1 helps keep skin stem cells inactive to prevent excessive cell growth.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Follistatin and LIN28B together improve the ability of inner ear cells in mice to regenerate into hearing cells.

Cyclosporin A promotes hair growth in mice and increases a protein linked to hair growth, but it may not work the same way in humans.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.